The intricacies of downstream signaling pathways and the cross-talk between MET and other molecules presented in this section indicate the complexity of gliomas; thus, drugs that inhibit single targets could be combined to achieve multiple target inhibition and obtain better treatment results. The gene discussed is MET; the disease is central nervous system cancer.